原发性雷诺现象与结缔组织病相关继发性雷诺现象的临床相关差异
基于PASRAP在线横断面调查,共1229例自报雷诺现象者,其中原发性218例(17.7%)、继发性1011例(82.3%,903例为系统性硬化症)。原发性者年龄更低、疼痛及神经感觉症状更多,继发性者发绀更常见且发作间期症状缓解更不完全。
要点
- 原发性雷诺现象者疼痛、麻木、刺痛和针刺感报告率均高于继发性者。
- 继发性者发作时发绀比例更高,发作间期症状完全缓解更少。
- 仅约半数受访者当前药物可充分控制症状,继发性者控制率略高。
核心结论
- 原发性与继发性雷诺现象在患者多维体验上存在临床相关差异,神经感觉症状在原发性者中更常见。
- 继发性者年龄更大、颜色改变(尤其发绀)更多、发作间期症状缓解更不完全。
研究设计与样本
- 报告PASRAP(雷诺现象患者体验调查)的横断面结果,该调查旨在探讨雷诺现象的广泛影响。
- 调查通过包括社交媒体在内的网络广泛发放,自愿参与且匿名应答。
- 共1229例自报雷诺现象受访者:原发性218例(17.7%),继发性1011例(82.3%),其中903例(92.9%)为系统性硬化症。
主要发现
- 原发性者平均(SD)年龄显著低于继发性者:41.7(11.8)岁 vs 54.2(12.4)岁,P<0.0001。
- 发作时继发性者报告发绀颜色改变的比例高于原发性者:92.2% vs 86.5%,P=0.0089。
- 原发性者报告疼痛(72.1% vs 55.9%,P<0.0001)、麻木(80.3% vs 69.4%,P=0.0016)、刺痛/搏动感(93.4% vs 80.8%,P<0.0001)及针刺感(84.0% vs 77.5%,P=0.0345)的比例均高于继发性者。
- 仅半数受访者症状被当前药物充分控制,继发性者控制率高于原发性者:55.2% vs 45.2%,P=0.0084。
- 两组在雷诺现象发作的诱因、次数及季节性变化方面存在重要差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Raynaud's phenomenon (RP) is a symptom complex associated with digital vascular compromise. Our aim was to examine for clinically relevant differences between primary RP (PRP) and secondary RP (SRP) to connective tissue disease. METHODS: We report cross-sectional results from the Patient Survey of experiences of Raynaud's Phenomenon (PASRAP), which aimed to explore the broad-ranging impact of RP. The survey was widely distributed online including via social medial. Participation was voluntary and responses were anonymous. RESULTS: 1229 respondents completed PASRAP with self-reported RP: PRP 218 (17.7 %) and SRP 1011 (82.3 %) of which 903 (92.9 %) Systemic Sclerosis. The mean (SD) age was significantly lower in respondents with PRP (41.7 [11.8] vs 54.2 [12.4] years, P<0.0001). During attacks, more subjects with SRP reported cyanotic colour changes (92.2 % vs 86.5 %, P=0.0089). Patients with PRP experienced more pain (72.1 % vs 55.9 %, P<0.0001), numbness (80.3 % vs 69.4 %, P=0.0016), stinging/throbbing (93.4 % vs 80.8 %, P<0.0001), and tingling (84.0 % vs 77.5 %, P=0.0345). Only half of respondents' symptoms were adequately controlled by their current medication(s), more commonly in SRP (55.2 % vs 45.2 %, P=0.0084). There were important differences in the triggers, number, and seasonal variation of RP attacks. CONCLUSION: There are clinically relevant differences between PRP and SRP concerning the multifaceted lived patient experience of RP. Neurosensory symptoms are more common in PRP. Patients with SRP are older and present with more colour changes, overrepresented by cyanosis, and with less complete resolution of symptoms between attacks. These data provide novel insights for future RP clinical trial design.
引用
- Di Donato S, Huang S, Pauling JD, et al. Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease. Semin Arthritis Rheum. 2024. PMID: 39089171. doi:10.1016/j.semarthrit.2024.152521
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。